CA2086258A1 - Pasteurella multocida toxoid vaccines - Google Patents

Pasteurella multocida toxoid vaccines

Info

Publication number
CA2086258A1
CA2086258A1 CA002086258A CA2086258A CA2086258A1 CA 2086258 A1 CA2086258 A1 CA 2086258A1 CA 002086258 A CA002086258 A CA 002086258A CA 2086258 A CA2086258 A CA 2086258A CA 2086258 A1 CA2086258 A1 CA 2086258A1
Authority
CA
Canada
Prior art keywords
pasteurella multocida
multocida
toxoid
toxoid vaccines
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002086258A
Other languages
French (fr)
Other versions
CA2086258C (en
Inventor
Joseph C. Frantz
David S. Roberts
Leroy A. Swearingin
Richard J. Kemmy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Joseph C. Frantz
David S. Roberts
Leroy A. Swearingin
Richard J. Kemmy
Smithkline Beecham Corporation
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joseph C. Frantz, David S. Roberts, Leroy A. Swearingin, Richard J. Kemmy, Smithkline Beecham Corporation, Pfizer Inc. filed Critical Joseph C. Frantz
Priority to CA002312296A priority Critical patent/CA2312296C/en
Priority claimed from PCT/US1991/004092 external-priority patent/WO1991019419A1/en
Publication of CA2086258A1 publication Critical patent/CA2086258A1/en
Application granted granted Critical
Publication of CA2086258C publication Critical patent/CA2086258C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

This invention provides vaccine compositions, methods of producing same and methods for protecting porcine animals against disease associated with infection by toxigenic Pasteurella multocida.
The vaccines of this invention contain effective amounts of a free, soluble P. multocida toxoid and/or a P. multocida bacterin with a cellbound toxoid.
CA002086258A 1990-06-13 1991-06-10 Pasteurella multocida toxoid vaccines Expired - Lifetime CA2086258C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002312296A CA2312296C (en) 1990-06-13 1991-06-10 Pasteurella multocida toxoid vaccines

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53745490A 1990-06-13 1990-06-13
US537,454 1990-06-13
PCT/US1991/004092 WO1991019419A1 (en) 1990-06-13 1991-06-10 Pasteurella multocida toxoid vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002312296A Division CA2312296C (en) 1990-06-13 1991-06-10 Pasteurella multocida toxoid vaccines

Publications (2)

Publication Number Publication Date
CA2086258A1 true CA2086258A1 (en) 1991-12-14
CA2086258C CA2086258C (en) 2007-10-23

Family

ID=38650016

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002086258A Expired - Lifetime CA2086258C (en) 1990-06-13 1991-06-10 Pasteurella multocida toxoid vaccines

Country Status (1)

Country Link
CA (1) CA2086258C (en)

Also Published As

Publication number Publication date
CA2086258C (en) 2007-10-23

Similar Documents

Publication Publication Date Title
CA2243755A1 (en) Streptococcal c5a peptidase vaccine
CA2082155A1 (en) Swine pneumonia vaccine and method of preparation
HUT62467A (en) Process for producing locally applicable pharmaceutical compositions comprising allylamine derivative, against fungus infection of nails
CA2089552A1 (en) Inactivated mycoplasma hyopneumoniae bacterin and method of use thereof
LU91595I2 (en) Combination of diphtheria toxoid, tetanus toxoid, pertussis toxoid, filamentous haemagglutinin, pertactin and capsular polysaccharide of haemophilus influenzae type b (InfanrixHib)
LU91924I2 (en) Vaccine composition comprising the polysaccharidecapsular and Haemophilus influenzae type b coupled to tetanus toxoid, diphtheria antigen, tetanus antigen, polio antigens, pertussis antigens and aluminum phosphate
CA2040544A1 (en) Actinobacillus pleuropneumoniae subunit vaccine
AU8314587A (en) New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
AU1362895A (en) Pasteurella multocida toxoid vaccines
CA2022420A1 (en) Escherichia coli vaccine
GR3017427T3 (en) Composition and method for protecting against diseases caused by microorganisms.
PL303482A1 (en) Vaccine against infection with streptococcus suis, streptococcus suis polypeptide and method of preparing such vaccine
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
NL990018I1 (en) Vaccine against Pasteurella.
WO1997045139A3 (en) Il-12 as an adjuvant for bordetella pertussis vaccines
WO1992006113A3 (en) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
CA2075711A1 (en) Vaccine and method therefor
MD1788F2 (en) Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases
CA2312296A1 (en) Pasteurella multocida toxoid vaccines
CA2086258A1 (en) Pasteurella multocida toxoid vaccines
EP0529019A4 (en) Nematode vaccine
GB9018061D0 (en) Compositions for vaccines
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
IT8722791A0 (en) ATTENUATED THUS OBTAINED. PROCEDURE FOR THE PREPARATION OF AN IMPROVED MUTANT STRAIN OF BORDETELLA BRONCHISEPTICA USEFUL FOR A LIVE ATTENUATED VACCINE FOR THE PROTECTION FROM B. BRONCHISEPTICA INFECTIONS AND LIVE AR VACCINE
CA2035474A1 (en) Vaccine protecting against pig haemophilosis

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry